Delivery Order SPE2DB20D1109-SPE2DB25FP26K
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $8,630.28 to AmerisourceBergen Drug Corp for 60 capsules of Ofev 100 mg on July 28, 2025, with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Ofev (nintedanib) is a specialized pharmaceutical used primarily in the treatment of pulmonary fibrosis and other...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Ofev 100 mg capsules (60-count units) with a ceiling value of $17,260.58. This firm fixed-price delivery order, which is expected to be completed by September 2, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. Ofev (nintedanib) is a medication...
- The Defense Logistics Agency awarded a $43,151.40 delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Ofev (nintedanib) 100 mg capsules in quantities of 60 units. This is a firm fixed price contract with an ultimate completion date of October 8, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to...
- The Defense Logistics Agency awarded a $51,543.48 delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Ofev (nintedanib) 150 mg capsules in quantities of 60 units. This is a firm fixed price delivery order with an ultimate completion date of October 2, 2025, and represents a non-competitive set-aside award. The contract will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Ofev is a specialty pharmaceutical used primarily in...
- The Defense Logistics Agency awarded a delivery order valued at $8,590.58 to AmerisourceBergen Drug Corp for OFEV (nintedanib) 150 mg capsules (60-count unit) on September 18, 2025, with an ultimate completion date of October 9, 2025. This is a firm fixed-price delivery order with no set-aside designation, performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen, a major pharmaceutical distributor and critical federal medical procurement vendor,...
- The Defense Logistics Agency awarded a delivery order valued at $8.6K to AmerisourceBergen Drug Corp for OFEV 100 mg capsules (60 count) on August 12, 2025, with completion targeted for September 3, 2025. This firm fixed-price delivery order was awarded without a set-aside designation through open competition and will be performed at the company's corporate headquarters in Conshohocken, Pennsylvania. OFEV (nintedanib) is a tyrosine kinase inhibitor primarily used to treat idiopathic pulmonary...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Ofev (nintedanib) 150 mg capsules in a quantity of 60 units, valued at $8,590.58. This is a firm fixed-price delivery order with an ultimate completion date of September 15, 2025, and was awarded on August 22, 2025, without a set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls...
- The Defense Logistics Agency awarded a delivery order valued at $8,630.28 to AmerisourceBergen Drug Corp for OFEV 100 mg capsules (60-count units) on September 4, 2025, with an ultimate completion date of September 25, 2025. This firm fixed-price delivery order was competitively awarded without a set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. OFEV (nintedanib) is a tyrosine kinase inhibitor used in the treatment of...
- The Defense Logistics Agency awarded a $17,181.16 delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Ofev (nintedanib) 150 mg capsules in a quantity of 60 units. This is a firm fixed price, non-set-aside contract with performance at the awardee's Conshohocken, Pennsylvania location and an ultimate completion date of October 8, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Ofev 150 mg capsules (60-count units) with a ceiling value of $8,590.58. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to support federal medical procurement needs. The contract specifies performance in Conshohocken, Pennsylvania, with an ultimate completion date of August 27, 2025. This delivery order is issued under...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB25FP26KDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $8.6K to AmerisourceBergen Drug Corp for 60-count bottles of Ofev 100 mg capsules. This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by July 11, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Ofev (nintedanib) is a specialty pharmaceutical used in the treatment of idiopathic pulmonary fibrosis and other progressive fibrosing interstitial lung diseases, reflecting the Defense Logistics Agency's procurement of specialized medications to support military healthcare needs. This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9M prime vendor agreement running through December 2026 that enables the contractor to supply comprehensive pharmaceutical and medical products globally to support military healthcare programs. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, maintains a significant portfolio of federal contracts with the Defense Logistics Agency Medical Supply Chain, demonstrating its capability to fulfill diverse federal medical procurement requirements through competitive awards across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.6k | 6/18/25 |